A Brief Report on the Role of SPECT/TC in the Optimization of Radiotherapy Treatment with Radical Intent for Unresectable Stage III NSCLC

<b>Background:</b> The standard treatment for locally advanced non-small cell lung cancer (LA-NSCLC) is represented by concomitant chemo-radiotherapy followed by consolidation with durvalumab that ensures a 5-year survival of 46%. However, the risk of radiotherapy-induced pneumonia (RIP)...

Full description

Bibliographic Details
Main Authors: Jessica Imbrescia, Giulia Volpi, Silvia Lucchini, Cristian Toraci, Giorgio Facheris, Salvatore La Mattina, Navdeep Singh, Filippo Vaccher, Andrea Guerini, Michela Buglione di Monale e Bastia, Alessio Bruni, Paolo Borghetti
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/12/18/9351